Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    0.00 (0.00%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Statement re Board Changes

25 Oct 2018 07:01

Board Changes

Dublin, London, 25 October 2018: C&C Group plc (‘C&C’ or the 'Group’), a leading manufacturer, marketer and distributor of branded cider, beer, wine and soft drinks today announces a series of changes to its Board of Directors.

Having overseen the smooth transition to a new Chairman, Richard Holroyd the Senior Non-Executive and Director since 2004 has informed the Board of his wish to step down and leave the Board in the new year. Geoffrey Hemphill a Non-Executive Director since 2017 has also informed of his intention to stand down from the Board to concentrate on other business interests.

On his appointment as Chairman Stewart Gilliland undertook a review of the composition of the Board to ensure that it has the right balance of skills and experience particularly in light of the strategically important acquisition of Matthew Clark and Bibendum.

The conclusion of this review was that the International Division would no longer be represented at the Group Board and the composition of the Board would be best comprised of a Chairman, 3 Executives (CEO, CFO and COO) and a reduced number of Non-Executive Directors.

Accordingly, Joris Brams as an Executive Director will stand down from the Board. Jim Clerkin, Vincent Crowley and Emer Finnan all Non-Executive Directors will remain in role and a search for new Non-Executive Directors with the appropriate skills and experience has commenced.

We are very grateful to Richard, Geoffrey and Joris for the individual contribution each of them has made to the Group’s long-term development.

ENDS

Contacts

C&C Group plc

Stephen Glancey | Group Chief Executive

Jonathan Solesbury | Chief Financial Officer

Joe Thompson | Head of Investor Relations

Tel: +44 7980 844 580

Email: Joe.Thompson@candcgroup.com

FTI Consulting

Mark Kenny/Jonathan Neilan/Paddy Berkery

Tel: +353 1 765 0886

Email: CandCGroup@fticonsulting.com

Novella Communications

Tim Robertson/Toby Andrews

Tel: +44 203 151 7008

Email: TimR@novella-comms.com

About C&C Group plc

C&C Group plc is a premium drinks company which owns, manufactures, markets and distributes branded beer, cider, wine, soft drinks and bottled water. C&C Group brands include: Bulmers the leading Irish cider brand; Tennent’s, the leading Scottish beer brand; Magners the premium international cider brand; as well as a range of super-premium and craft ciders and beers. C&C Group also owns and manufactures Woodchuck, a leading craft cider brand in the United States and manufactures and distributes a number of 3rd party international beer brands in Scotland and Ireland. C&C is also a leading drinks wholesaler in the UK and Ireland, where it operates under the Matthew Clark, Bibendum, Tennent's and C&C Gleeson brands. C&C Group has a minority investment in the Admiral Taverns tenanted pub group, which owns over 850 pubs across England & Wales. C&C Group is headquartered in Dublin with manufacturing operations in Co.Tipperary, Ireland; Glasgow, Scotland; and Vermont, US. C&C Group plc is listed on the Irish and London Stock Exchanges.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181024006006/en/

Copyright Business Wire 2018

Date   Source Headline
2nd Jun 20177:00 amRNSTransaction in Own Shares
1st Jun 20174:20 pmRNSDirector/PDMR Shareholding
1st Jun 20171:28 pmRNS2017 Final Dividend - Scrip Alternative
1st Jun 20179:25 amRNSTotal Voting Rights
1st Jun 20177:05 amBUSDirector Declaration
1st Jun 20177:00 amRNSBlock Listing Six Monthly Return
1st Jun 20177:00 amRNSTransaction in Own Shares
1st Jun 20177:00 amBUSDirectorate change
26th May 20176:05 pmRNSTransaction in Own Shares
26th May 20177:00 amRNSTransaction in Own Shares
25th May 20174:00 pmRNSDirector/PDMR Shareholding
23rd May 20178:59 amRNSHolding(s) in Company
19th May 20177:05 amBUSDirector Declaration
19th May 20177:00 amBUSStatement re Appointment of Non-executive Director
17th May 20177:00 amBUSFinal Results
16th May 20178:29 amRNSHolding(s) in Company
9th May 20179:23 amRNSHolding(s) in Company
8th May 20177:00 amBUSNotice of Results
2nd May 20172:10 pmRNSTotal Voting Rights
13th Apr 20175:31 pmRNSDirector/PDMR Shareholding
7th Apr 20178:52 amRNSHolding(s) in Company
3rd Apr 20175:51 pmRNSHolding(s) in Company
3rd Apr 201710:11 amRNSTransaction in Own Shares - Replacement
3rd Apr 201710:02 amRNSTotal Voting Rights
3rd Apr 20177:00 amBUSTransaction in Own Shares
31st Mar 20178:46 amRNSDirector Declaration
31st Mar 20177:00 amBUSDirectorate change
20th Mar 20179:06 amRNSHolding(s) in Company
10th Mar 20177:00 amBUSStatement re Pre-Close Trading Update
8th Mar 20174:52 pmRNSHolding(s) in Company
7th Mar 20173:00 pmBUSStatement re Notice of Pre-Close Trading Update
7th Mar 20177:00 amRNSHolding(s) in Company
1st Mar 201710:11 amRNSTotal Voting Rights
28th Feb 20174:07 pmRNSHolding(s) in Company
24th Feb 20178:59 amRNSHolding(s) in Company
16th Feb 20176:02 pmRNSDirector/PDMR Shareholding
8th Feb 201712:32 pmRNSHolding(s) in Company
8th Feb 201712:29 pmRNSHolding(s) in Company
7th Feb 20174:18 pmRNSHolding(s) in Company
1st Feb 20175:00 pmRNSHolding(s) in Company
1st Feb 201712:16 pmRNSTotal Voting Rights
3rd Jan 201710:13 amRNSTotal Voting Rights
22nd Dec 20164:30 pmRNSDirector/PDMR Shareholding
21st Dec 20162:47 pmRNSDirector/PDMR Shareholding
21st Dec 20169:00 amBUSStatement re Death of Non-Executive Director
16th Dec 20167:00 amRNSMain Securities Market Notice
14th Dec 20167:00 amRNSScrip Alternative - Additional Listing
12th Dec 20167:00 amBUSAgreement
1st Dec 201611:22 amRNSBlocklisting Six Monthly Return
1st Dec 201611:19 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.